Size distribution analysis of residual host cell DNA fragments in lentivirus by CGE-LIF
- PMID: 36353919
- DOI: 10.1002/elps.202200218
Size distribution analysis of residual host cell DNA fragments in lentivirus by CGE-LIF
Abstract
During the production of cell and gene therapy products, residual host cell DNA (HCD) could cause safety risks of the biological products, and the longer the residual HCD fragment, the greater the risk to the human body. For this reason, it was necessary to develop an effective method for the size distribution analysis of residual HCD fragments with high accuracy and sensitivity. In this study, capillary gel electrophoresis with laser-induced fluorescence detector (CGE-LIF) was used to analyze the size distribution of residual HCD fragments in lentivirus products. The results confirmed that lentiviral RNA genome could interfere with the size distribution analysis of residual HCD fragments. By optimizing the amount of RNase I and digestion time in sample pretreatment process, the interfere of RNA genome could be avoided. The specificity, precision, accuracy, linear range, the detection of limit (LOD), and the quantification of limit (LOQ) of CGE-LIF method were also validated. The results showed that the CGE-LIF method had a good performance both in terms of specificity and reproducibility. The intra- and inter-day relative standard deviations of migration time and corrected peak area were all less than 1% and 2%, respectively. The 200 bp DNA marker had a good linearity between 50 and 1000 pg/ml. The LOD and LOQ of 200 bp DNA marker were 2.59 and 8.64 pg/ml, respectively. In addition, this method was successfully used to analyze the size distribution analysis of residual HCD fragments in lentivirus products with different production processes.
Keywords: capillary gel electrophoresis; cell and gene therapy; distribution analysis; lentivirus; residual host cell DNA.
© 2022 Wiley-VCH GmbH.
Similar articles
-
Sensitive and simultaneous analysis of five transgenic maizes using multiplex polymerase chain reaction, capillary gel electrophoresis, and laser-induced fluorescence.Electrophoresis. 2004 Jul;25(14):2219-26. doi: 10.1002/elps.200405983. Electrophoresis. 2004. PMID: 15274006
-
Fast molecular diagnostics of canine T-cell lymphoma by PCR and capillary gel electrophoresis with laser-induced fluorescence detector.J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jul 1;854(1-2):268-72. doi: 10.1016/j.jchromb.2007.04.050. Epub 2007 May 17. J Chromatogr B Analyt Technol Biomed Life Sci. 2007. PMID: 17543593
-
Size analysis of residual host cell DNA in cell culture-produced vaccines by capillary gel electrophoresis.Biologicals. 2013 May;41(3):201-8. doi: 10.1016/j.biologicals.2012.12.001. Epub 2013 Jan 10. Biologicals. 2013. PMID: 23313102
-
CGE-laser induced fluorescence of double-stranded DNA fragments using GelGreen dye.Electrophoresis. 2013 Jun;34(11):1555-62. doi: 10.1002/elps.201200624. Epub 2013 Apr 23. Electrophoresis. 2013. PMID: 23417332
-
Use of capillary electrophoresis methods to characterize the pharmacokinetics of antisense drugs.Electrophoresis. 1998 Nov;19(16-17):2861-9. doi: 10.1002/elps.1150191612. Electrophoresis. 1998. PMID: 9870381 Review.
Cited by
-
Evaluation of the Efficacy of the Vaccine Production Process in Removing Residual Host Cell DNA from the Vero Cell Rabies Vaccine.Vaccines (Basel). 2024 Dec 6;12(12):1379. doi: 10.3390/vaccines12121379. Vaccines (Basel). 2024. PMID: 39772041 Free PMC article.
-
Quality assessment strategy development and analytical method selection of GMP grade biological drugs for gene and cell therapy.BBA Adv. 2025 Feb 19;7:100151. doi: 10.1016/j.bbadva.2025.100151. eCollection 2025. BBA Adv. 2025. PMID: 40094061 Free PMC article. Review.
-
Application of capillary gel electrophoresis in detection of Factor VIII gene intron 22 inversion of hemophilia A.J Hematop. 2025 Aug 18;18(1):40. doi: 10.1007/s12308-025-00655-5. J Hematop. 2025. PMID: 40824325
References
REFERENCES
-
- Carter PJ, Rajpal A. Designing antibodies as therapeutics. Cell. 2022;185:2789-805.
-
- Iwasaki A, Omer SB. Why and how vaccines work. Cell. 2020;183:290-5.
-
- Katherine AH, Maria GR. Gene therapy. N Engl J Med. 2019;381:455-64.
-
- Mariniello K, Guasti L. Towards novel treatments for adrenal diseases: cell-and gene therapy-based approaches. Mol Cell Endocrinol. 2021;524:111160.
-
- Ma CC, Wang ZL, Xu T, He ZY, Wei YQ. The approved gene therapy drugs worldwide: from 1998 to 2019. Biotechnol Adv. 2020;40:107502.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources